Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
about
Vaccines for TB: Lessons from the Past Translating into Future PotentialsEffect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa.Point-of-care Arkansas method for measuring adherence to treatment with isoniazidRisk factors for non-adherence and loss to follow-up in a three-year clinical trial in BotswanaAntiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settings.Provision and awareness for isoniazid preventive therapy among PLHIV in Addis Ababa, EthiopiaEpidemiology of HIV-associated tuberculosis.The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.Determinant factors associated with occurrence of tuberculosis among adult people living with HIV after antiretroviral treatment initiation in Addis Ababa, Ethiopia: a case control studyNovel developments in the epidemic of human immunodeficiency virus and tuberculosis coinfectionDiagnosing latent tuberculosis in high-risk individuals: rising to the challenge in high-burden areas.Epidemiology of Respiratory Disease in Malawi.Implementation and evaluation of an isoniazid preventive therapy pilot program among HIV-infected patients in Vietnam, 2008-2010Tuberculosis preventive therapy in the era of HIV infection: overview and research priorities.Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.Human immunodeficiency virus-associated tuberculosis: update on prevention and treatmentPediatric TB: issues related to current and future treatment options.Tuberculosis and HIV co-infection: screening and treatment strategies.Implementing isoniazid preventive therapy in a tuberculosis treatment-experienced cohort on ART.Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions.High burden of prevalent tuberculosis among previously treated people in Southern Africa suggests potential for targeted control interventions.Recurrent tuberculosis: relapse, reinfection, and HIV.Effectiveness and safety of isoniazid chemoprophylaxis for HIV-1 infected patients from Rio de Janeiro.Efficacy of a 6-month versus 9-month intermittent treatment regimen in HIV-infected patients with tuberculosis: a randomized clinical trial.The sound of one hand clapping: tuberculosis and antiretroviral therapy in Africa.Occupational lung disease in the South African mining industry: research and policy implementation.Facilitating interaction between TB and AIDS medical services for better management of patients with co-infections.Tuberculosis control interventions targeted to previously treated people in a high-incidence setting: a modelling study.HIV and tuberculosis coinfection: inextricably linked liaisonHIV remains a deadly disease
P2860
Q26996673-1628C5E5-D67D-4E04-BD9D-D6BFD44BAB18Q30240445-23F2AF0F-28BE-4DD2-8D8C-B395E94C89CDQ33246696-57A691E1-AA2A-4D94-B4C0-D16F1E10896EQ33823374-7F5D5021-F907-415A-8CAD-AC6D364B82E8Q33889133-D58E1792-9309-43B9-96E0-C16243663562Q33920318-779EC5CC-9B6C-40EA-A9A2-6F82F8A451E1Q34209499-28659446-118B-421B-9D01-F5CB2FF569CAQ34519940-DB8907C9-4125-4466-8D78-B6B45B52B766Q34717877-205CBB6D-5466-423B-B531-E3A8799492EFQ34717889-2516104F-CBE9-4DB8-B696-C56247A61279Q34769326-1A205EF4-2DDF-419E-B17B-FDBB36CE4F95Q34914625-AB534A33-6BA6-4DFD-80D9-C3F24F128C55Q35336540-14285A01-C2D9-4F56-ADA4-1FE0E8060687Q35937990-B8E207A1-DCEB-493F-82F1-7CCE31D50A56Q36702386-A0756D39-DE9D-45D9-818B-4EFB13FBC6D3Q36877233-6D3731D6-99E8-4EA2-BE04-84C50E56A8C6Q37015711-60CF10F4-0503-4508-9397-1CBD79D4A9A5Q37103666-2C188B9A-04B0-4C88-BE3A-DE9DDFFF88D9Q37573756-FF1353D1-191F-49A7-B84D-858432F833A1Q37895251-ADDC138E-E642-4550-B886-A7ACE18429ECQ38841837-297898D4-CB85-4495-B85C-5D2AB8B06A7DQ39448183-500F90BF-1153-4DFB-A4C0-C27BC2E2F931Q39747436-D559152A-C9F0-4BBB-8D98-FA8C5B25EF5BQ41641226-60723B86-E9F0-4048-9475-5345BD6CC97BQ42076385-CE2790F2-9E83-4DC7-AEFF-2EEA41403B0BQ42625458-6CC6AB00-7206-400A-8A74-95FB01EFBFCBQ43228809-5C64900F-4785-45BB-8244-915953F15FA7Q46351467-F6B937D5-F588-462F-AEEF-D358970F83D7Q46532712-30E54F40-28E5-4BE2-8B46-4D0A83FF2328Q47872780-F1E7AEDE-6F1B-4B78-8C0A-BE593EBD95D3Q51409194-7D705BE8-1751-4B8C-9293-AF38ABE0D1D9Q56997810-B83B0CD5-2370-4E69-B0CC-52543F1E1C2BQ57877804-203679B0-CE00-4DE2-9ED4-AC3F0838F0CE
P2860
Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy?
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@en
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@nl
type
label
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@en
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@nl
prefLabel
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@en
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@nl
P2093
P50
P1433
P1476
Efficacy of secondary isoniazi ...... ricans: time to change policy?
@en
P2093
Alison D Grant
Badara Samb
John H Day
Kevin M De Cock
P304
P356
10.1097/00002030-200309260-00007
P407
P50
P577
2003-09-01T00:00:00Z